SG158776A1 - Using genetic polymorphisms of the bicd1 gene as a method for diagnosing and treating myopia - Google Patents

Using genetic polymorphisms of the bicd1 gene as a method for diagnosing and treating myopia

Info

Publication number
SG158776A1
SG158776A1 SG200805610-3A SG2008056103A SG158776A1 SG 158776 A1 SG158776 A1 SG 158776A1 SG 2008056103 A SG2008056103 A SG 2008056103A SG 158776 A1 SG158776 A1 SG 158776A1
Authority
SG
Singapore
Prior art keywords
myopia
diagnosing
subject
genetic polymorphisms
bicd1 gene
Prior art date
Application number
SG200805610-3A
Inventor
Suh-Hang Hank Juo
Original Assignee
Univ Kaohsiung Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kaohsiung Medical filed Critical Univ Kaohsiung Medical
Priority to SG200805610-3A priority Critical patent/SG158776A1/en
Publication of SG158776A1 publication Critical patent/SG158776A1/en

Links

Abstract

Using the BICD1 gene as a method for diagnosing myopia and/or myopia related complications is provided. The method includes obtaining a biological sample from a subject, and determining at least one SNP genotype in the BICD1 gene in the biological sample, wherein the presence of the SNP genotype indicates that the subject is susceptible to myopia. The SNP genotype is selected from the group consisting of SNPs rs7966276, rs1151029, rs2650122, and rsl0771923. In addition, the present invention also provides a method of screening a material for preventing, treating myopia, and a method of assessing a subject for probability of response to a myopia therapeutic agent.
SG200805610-3A 2008-07-25 2008-07-25 Using genetic polymorphisms of the bicd1 gene as a method for diagnosing and treating myopia SG158776A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG200805610-3A SG158776A1 (en) 2008-07-25 2008-07-25 Using genetic polymorphisms of the bicd1 gene as a method for diagnosing and treating myopia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG200805610-3A SG158776A1 (en) 2008-07-25 2008-07-25 Using genetic polymorphisms of the bicd1 gene as a method for diagnosing and treating myopia

Publications (1)

Publication Number Publication Date
SG158776A1 true SG158776A1 (en) 2010-02-26

Family

ID=41716837

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200805610-3A SG158776A1 (en) 2008-07-25 2008-07-25 Using genetic polymorphisms of the bicd1 gene as a method for diagnosing and treating myopia

Country Status (1)

Country Link
SG (1) SG158776A1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050026169A1 (en) * 2002-12-20 2005-02-03 Applera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
US20060024715A1 (en) * 2004-07-02 2006-02-02 Affymetrix, Inc. Methods for genotyping polymorphisms in humans
WO2006022639A1 (en) * 2004-07-21 2006-03-02 Applera Corporation Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof
US20070048756A1 (en) * 2005-04-18 2007-03-01 Affymetrix, Inc. Methods for whole genome association studies
US20070054278A1 (en) * 2003-11-18 2007-03-08 Applera Corporation Polymorphisms in nucleic acid molecules encoding human enzyme proteins, methods of detection and uses thereof
US20070083334A1 (en) * 2001-09-14 2007-04-12 Compugen Ltd. Methods and systems for annotating biomolecular sequences
WO2008130008A1 (en) * 2007-04-17 2008-10-30 Santen Pharmaceutical Co., Ltd. Method for determination of onset risk of glaucoma

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070083334A1 (en) * 2001-09-14 2007-04-12 Compugen Ltd. Methods and systems for annotating biomolecular sequences
US20050026169A1 (en) * 2002-12-20 2005-02-03 Applera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
US20070054278A1 (en) * 2003-11-18 2007-03-08 Applera Corporation Polymorphisms in nucleic acid molecules encoding human enzyme proteins, methods of detection and uses thereof
US20060024715A1 (en) * 2004-07-02 2006-02-02 Affymetrix, Inc. Methods for genotyping polymorphisms in humans
WO2006022639A1 (en) * 2004-07-21 2006-03-02 Applera Corporation Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof
US20070048756A1 (en) * 2005-04-18 2007-03-01 Affymetrix, Inc. Methods for whole genome association studies
WO2008130008A1 (en) * 2007-04-17 2008-10-30 Santen Pharmaceutical Co., Ltd. Method for determination of onset risk of glaucoma

Similar Documents

Publication Publication Date Title
WO2009059321A3 (en) Rca locus analysis to assess susceptibility to amd and mpgnii
NZ596614A (en) Diagnosis and treatment of alzheimer's disease
NZ588037A (en) Serotonin transporter gene SLC6A4 and treatment of alcoholism
EA200971079A1 (en) GENETIC OPTIONS IN CHR5P12 AND 10Q26 AS MARKERS FOR RISK ASSESSMENT, DIAGNOSIS, PREDICTION AND TREATMENT OF BREAST
WO2008079374A3 (en) Methods and compositions for selecting and using single nucleotide polymorphisms
WO2010018601A3 (en) Genetic variants predictive of cancer risk
WO2010004591A3 (en) Genetic variants for breast cancer risk assessment
NZ600235A (en) Methods and compositions for the assessment of drug response
NZ593628A (en) Genetic variants useful for risk assessment of thyroid cancer using rs944289
WO2008132763A3 (en) Genetic variants useful for risk assessment of coronary artery disease and myocardial infarction
WO2008137762A3 (en) Methods of diagnosis and treatment of crohn's disease
WO2008117314A3 (en) Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
WO2007085497A3 (en) Markers for the prediction of outcome of anthracycline treatment
WO2010103292A3 (en) A genotyping tool for improving the prognostic and clinical management of ms patients
SI1730315T1 (en) Polymorphisms in nod2/card15 gene
WO2007058968A3 (en) Gene expression profiles and methods of use
NZ599110A (en) Genetic polymorphisms in age-related macular degeneration
WO2007110623A3 (en) Screening method
WO2011133949A3 (en) Genetic risk analysis in reward deficiency syndrome
WO2008089465A3 (en) Gene polymorphisms as sex-specific predictors in cancer therapy
KR20160009582A (en) Variants of tnfsf15 and dcr3 associated with crohn's disease
WO2008137121A3 (en) Methods for detecting an increased risk for coronary heart disease
WO2005112568A3 (en) Haplotype markers and methods of using the same to determine response to treatment
WO2007063405A3 (en) Diagnosis and treatment of exocrine pancreatic dysfunction and diabetes using human cel gene
WO2008065544A3 (en) Genetic predictors of risk for type 2 diabetes mellitus